The CEO's $2.38M sale is the dominant signal in this cluster. While insider sales are often liquidity-driven, a CEO selling this amount in a concentrated window without a disclosed 10b5-1 plan raises the risk of negative near-term catalysts (e.g., clinical trial readout disappointment, cash burn concerns). Monitor for any upcoming press releases or data disclosures.
Price Chart
Executive Summary
Three insiders at CRISPR Therapeutics sold a total of ~$3.15M in open-market sales within a week, including the CEO ($2.38M), a director ($720K), and the general counsel ($51K). The CEO's sale is the largest and most notable, occurring at ~$49.78 per share. While the dollar amount is modest relative to the company's market cap (likely <0.5%), the involvement of the CEO in a concentrated cluster warrants attention.
Key Financial Metrics
Key Facts
- CEO Samarth Kulkarni sold 47,800 shares at ~$49.78 for $2.38M on 2026-10-19
- Director George Simeon sold 14,514 shares at $49.63 for $720K on 2026-10-14
- General Counsel James R. Kasinger sold 1,040 shares at $49.26 for $51K on 2026-10-14
- Total open-market sales: ~$3.15M across three insiders in a 7-day window
- Director Simeon also exercised derivative transactions (60,000 shares total) on the same day as his sale, suggesting a cashless exercise-and-sell pattern
Financial Impact
~$3.15M in insider open-market sales, likely <0.5% of market cap
Risk Factors
- CEO selling a large position without a pre-arranged plan may signal bearish conviction
- Director exercising and immediately selling suggests no strong bullish view from the board
- No insider buying to offset the selling cluster
Investment Themes
Documents Analyzed
This report is based on 1 SEC document filed with EDGAR.
| Document | Accession Number |
|---|---|
| CLUSTER Data (Synthetic) | cluster-CRSP-1792618940532 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Oct 20, 2026 6d ago | Insider Cluster | $50.50 | awaiting T+20 | — | $49.01 (+2.95%) |
Oct 19, 2026 7d ago | 8-K | $49.88 | awaiting T+20 | — | $49.01 (−1.74%) |
Oct 16, 2026 10d ago | Insider Cluster | $50.04 | awaiting T+20 | — | $49.01 (−2.06%) |
Oct 16, 2026 10d ago | Insider Cluster | $50.04 | awaiting T+20 | — | $49.01 (+2.06%) |
Oct 15, 2026 11d ago | Insider Cluster | $49.25 | awaiting T+20 | — | $49.01 (−0.49%) |
Oct 14, 2026 12d ago | 144 | $51.52 | awaiting T+20 | — | $49.01 (−4.87%) |
Oct 6, 2026 20d ago | 144 | $52.35 | awaiting T+20 | — | $49.01 (−6.38%) |
Sep 24, 2026 4w ago | Insider Cluster | $54.23 $49.39 | ▲ +8.92% | ▲ +7.45% | $49.01 (+9.63%) |
Aug 28, 2026 8w ago | Press Release | $57.72 $54.23 | ▼ −6.05% | ▼ −6.56% | $49.01 (−15.09%) |
Aug 3, 2026 12w ago | Press Release | $53.07 $56.82 | ▲ +7.07% | ▲ +8.30% | $49.01 (−7.65%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers